Skip to main content
VCbacked
Log inGet Started

Intensity Therapeutics

Norwalk, United States

Intensity Therapeutics is a biopharmaceutical company that provides chemotherapy treatment for cancer patients.

$4.0M raised
Oct 2025
Post-IPO Equity
BiopharmaBiotechnologyTherapeutics

Top Investors

VCapitalJim MellonDeclan DooganBatterson Venture CapitalSalvaRx Group PLC

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Intensity Therapeutics

How much funding has Intensity Therapeutics raised?
Intensity Therapeutics has raised $4.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2025.
Who are Intensity Therapeutics's investors?
Intensity Therapeutics's investors include VCapital, Jim Mellon, Declan Doogan, Batterson Venture Capital, SalvaRx Group PLC.
Where is Intensity Therapeutics headquartered?
Intensity Therapeutics is headquartered in Norwalk, United States.
What does Intensity Therapeutics do?
Intensity Therapeutics is a biopharmaceutical company that provides chemotherapy treatment for cancer patients.
What stage is Intensity Therapeutics at?
Intensity Therapeutics is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Intensity Therapeutics — Funding & Investors." VCBacked, October 31, 2025, https://www.vcbacked.co/company/intensity-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2025). Intensity Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/intensity-therapeutics
Wikipedia (cite web)
{{cite web |title=Intensity Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/intensity-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
Allterum Therapeutics
Houston$1.0M
Epsilogen
London$16.3M
Cairn Therapeutics
Tucson$3.0M
Living In Silico Inc.
Brampton$3K
KuriBio
Berkeley$150K
Systemic Bio
Houston$15.0M